Medication Review Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Medication Review

Access the complete profile.

Medication Review Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5416 Management, Scientific & Technical Consulting Services
Address	1206 N. Lincoln Street, Suite 101 Spokane, WA 99201

Note: Revenues for privately held companies are statistical evaluations.


Medication Review's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Medication Review's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Medication Review is classified as operating in the Management, Scientific & Technical Consulting Services industry, NAICS Code 5416.

Medication Review Annual Revenue and Growth Rate

Medication Review	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Medication Review's revenues are gauged from an analysis of company filings.

Medication Review's Income Statement (based on Industry Averages)

Medication Review P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Medication Review has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
March 22, 2012	1	0%	$3 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Medication Review is developing and marketing. Medication Review doesn't have any recent trademark applications, indicating Medication Review is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
MEDICATION REVIEW Management and business consulting services in the field of pharmacy and telepharmacy	03/31/2011

See all trademarks and details in the Full Report.

Market Share of Medication Review's Largest Competitors

A competitive analysis shows these companies are in the same general field as Medication Review, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LCP HAMPTON BEACH HOSPITALITY	Plymouth, MA	100
BOOZ ALLEN HAMILTON	Mclean, VA	16
ACCENTURE	Chicago, IL	14
MCKINSEY	New York, NY	12
DELAWARE NORTH COMPANIES	Buffalo, NY	6
ATLAS TECHNOLOGY SOLUTIONS	Chicago, IL	5
MAXIMUS SERVICES	Mclean, VA	5
WILLIS TOWERS WATSON US	Arlington, VA	4
KBR HOLDINGS	Houston, TX	3

Nearby Competitors

These companies are similar in business line and location to Medication Review. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
IGNITIUM	Spokane, WA	100
LILAC CITY BEHAVIORAL SERVICES PLLC	Spokane, WA	64
MEDICATION REVIEW	Spokane, WA	32
SAPERE CONSULTING	Spokane, WA	28
AIR TECH ABATEMENT TECHNOLOGIES	Spokane, WA	26
KEYSTONE MEDICAL MANAGEMENT	Spokane, WA	20

Future Competition: Medication Review's Fastest Growing Competitors

These companies are in the same general field as Medication Review and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)